Kbc Group Nv Bio Rad Laboratories, Inc. Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 2,281 shares of BIO stock, worth $605,902. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,281

Previous 3,095 26.3%

Holding current value

$605,902

Previous $1.04 Million 27.7%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$313.15 - $374.28 $254,904 - $304,663	-814 Reduced 26.3%	2,281 $749,000
Q3 2024 Nov 06, 2024	BUY	$263.97 - $344.64 $369,558 - $482,496	1,400 Added 82.6%	3,095 $1.04 Million
Q2 2024 Jul 17, 2024	SELL	$268.26 - $339.48 $149,420 - $189,090	-557 Reduced 24.73%	1,695 $463,000
Q1 2024 May 08, 2024	SELL	$304.11 - $351.99 $317,490 - $367,477	-1,044 Reduced 31.67%	2,252 $779,000
Q4 2023 Feb 13, 2024	SELL	$269.37 - $365.04 $386,545 - $523,832	-1,435 Reduced 30.33%	3,296 $1.06 Million
Q3 2023 Feb 15, 2024	SELL	$350.25 - $422.63 $191,937 - $231,601	-548 Reduced 10.19%	4,830 $1.73 Million
Q2 2023 Feb 15, 2024	BUY	$359.49 - $486.4 $1.35 Million - $1.83 Million	3,760 Added 232.39%	5,378 $2.04 Million
Q2 2023 Jul 28, 2023	BUY	$359.49 - $486.4 $681,593 - $922,214	1,896 Added 66.88%	4,731 $1.79 Million
Q1 2023 Feb 14, 2024	SELL	$418.69 - $503.0 $118,907 - $142,852	-284 Reduced 7.32%	3,597 $1.72 Million
Q1 2023 May 04, 2023	BUY	$418.69 - $503.0 $521,269 - $626,235	1,245 Added 78.3%	2,835 $1.36 Million
Q4 2022 Feb 14, 2024	BUY	$351.71 - $456.01 $805,767 - $1.04 Million	2,291 Added 144.09%	3,881 $1.63 Million
Q3 2022 Feb 15, 2024	SELL	$412.59 - $563.26 $692,326 - $945,150	-1,678 Reduced 50.91%	1,618 $675,000
Q2 2022 Feb 14, 2024	BUY	$463.67 - $597.16 $37,093 - $47,772	80 Added 5.3%	1,590 $787,000
Q2 2022 Jul 26, 2022	BUY	$463.67 - $597.16 $37,093 - $47,772	80 Added 5.3%	1,590 $787,000
Q1 2022 Feb 14, 2024	SELL	$524.57 - $735.42 $15.5 Million - $21.8 Million	-29,581 Reduced 95.14%	1,510 $850,000
Q1 2022 May 06, 2022	SELL	$524.57 - $735.42 $15.5 Million - $21.8 Million	-29,581 Reduced 95.14%	1,510 $850,000
Q4 2021 Feb 14, 2024	BUY	$708.84 - $794.68 $19.7 Million - $22.1 Million	27,795 Added 843.29%	31,091 $23.5 Million
Q4 2021 Feb 03, 2022	SELL	$708.84 - $794.68 $1.31 Million - $1.47 Million	-1,844 Reduced 5.6%	31,091 $23.5 Million
Q3 2021 Nov 10, 2021	BUY	$657.71 - $825.77 $19.2 Million - $24.1 Million	29,143 Added 768.54%	32,935 $24.6 Million
Q2 2021 Aug 11, 2021	BUY	$576.64 - $649.04 $388,078 - $436,803	673 Added 21.58%	3,792 $2.44 Million
Q1 2021 Apr 26, 2021	BUY	$547.01 - $662.35 $426,120 - $515,970	779 Added 33.29%	3,119 $1.78 Million
Q3 2020 Oct 28, 2020	SELL	$454.43 - $535.6 $15.6 Million - $18.4 Million	-34,372 Reduced 93.63%	2,340 $1.21 Million
Q2 2020 Aug 10, 2020	BUY	$334.87 - $493.06 $5.83 Million - $8.59 Million	17,420 Added 90.3%	36,712 $16.6 Million
Q1 2020 May 04, 2020	BUY	$320.01 - $409.07 $5.67 Million - $7.25 Million	17,723 Added 1129.57%	19,292 $6.76 Million
Q4 2019 Feb 11, 2020	BUY	$319.73 - $374.2 $501,656 - $587,119	1,569 New	1,569 $581,000

Others Institutions Holding BIO

# of Institutions

477

Shares Held

19.2M

Call Options Held

15.7K

Put Options Held

11.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.54B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account